Home » Health » Diabetes Drug Shortages: Risks for Seniors & What to Do

Diabetes Drug Shortages: Risks for Seniors & What to Do

by Dr. Michael Lee – Health Editor

sweden Faces ongoing⁤ Drug Shortages, Leaving Patients Like Kent Without Critical Medication

Kent, a Swedish man ‍with diabetes, recently found ​himself without ‌his essential ​medication due⁤ to ​recurring drug shortages impacting the ‍nation.⁤ His experience underscores a ​problem that, while recently gaining‍ visibility, is‍ not new, according to investigators at the Swedish medicines Agency. The shortages are ​creating insecurity for‌ individuals and their families, ⁣as access to necessary prescriptions becomes unpredictable.

While recent media⁢ coverage​ suggests a sudden⁤ surge in drug scarcity, Samuel Silkestrand, an investigator at the⁤ Swedish Medicines Agency,‌ states that⁣ “scarce situations are not a new‌ phenomenon,” citing news articles documenting residual drug situations dating back 10-15 years. The issue gained increased attention in 2018 when the agency ⁣began tracking residual listings, providing a clearer⁢ picture ⁤of⁤ the problem’s scope. Currently, ⁣Sweden operates at a “moderate impact”‌ level (2) on the ‍agency’s five-degree​ scale of drug shortages.

The most common causes ⁣of these deficiencies are manufacturing problems, ‍followed by high demand. Specific medications experiencing shortages between January and April included immune stimulants, asthma drugs for children, certain antibiotics, and some cytostatic ‍drugs used in cancer treatment. To mitigate the risk,the National Board ​of Health and welfare recommends individuals maintain a month’s⁤ supply of prescribed medications ⁢at home. Silkestrand advises patients ⁤not to wait‍ until their three-month prescription is fully depleted⁣ before requesting a ⁤refill, noting the opportunity to pick⁣ up medication after two months.A state investigation proposed in april suggests‌ granting the Swedish Medicines Agency the authority to limit the export of dwindling medications,​ prioritizing access ‍for those with the ‌greatest need.​ The agency currently⁤ classifies the impact of shortages as‌ moderate, but the situation continues to raise​ concerns about patient​ care and access to vital treatments.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.